Double T-Pouch

The Double T Pouch is a continent cutaneous ileal urinary reservoir that applies the serosal-lined extramural T-mechanism flap valve at both ends of the reservoir — as an afferent antireflux mechanism (preventing ureteral reflux) and as an efferent continence mechanism (preventing urine leakage through the catheterizable stoma). It was developed by John P. Stein and Donald G. Skinner at the University of Southern California as a cutaneous adaptation of their orthotopic T Pouch neobladder, first formally described in 2001.^[1][2]

Historical Development — From Kock to T to Double T

The Double T Pouch represents the culmination of a decades-long USC effort to eliminate the complications of the intussuscepted nipple valve used in the Kock pouch.

• 1982–1996 — USC was the world's leading center for the Kock ileal reservoir (>531 cases). The defining complications were intussuscepted-afferent-nipple-valve problems — stones on exposed staples, stenosis, extussusception. Reoperation rate 10–22%.^[3]
• 1996–1998 — Stein, Lieskovsky, Ginsberg, Bochner, and Skinner developed the T Pouch — an orthotopic ileal neobladder that replaced the intussuscepted afferent nipple with a novel serosal-lined extramural ileal tunnel (the "T-mechanism") for antireflux. First 40 patients reported in 1998 with no reflux, no late complications, and all upper tracts unchanged or improved.^[4]
• 1998 — Bochner et al. published the in vivo fluorourodynamic validation of the serosal-lined antireflux valve in a pig model, demonstrating that a tunnel length-to-luminal-diameter ratio of ≥ 2:1 is required for reliable function at pressures up to 100 cm H₂O.^[5]
• 2001 — Stein and Skinner published the definitive description of the T-mechanism applied to urinary diversion, describing both the orthotopic T Pouch (single T-mechanism for antireflux) and the cutaneous Double T Pouch (two T-mechanisms — antireflux + continence).^[1][2]
• 2002 — Marino and Laudi (Italy) reported the first independent clinical series of the ileal cutaneous T Pouch — 18 patients with 100% continence day and night, no late complications, good capacity / low pressure, and no reflux.^[6]
• 2003 — Kurzrock, Skinner, and Stein adapted the concept to a Hemi-T Pouch for pediatric urinary diversion when the appendix was unavailable.^[7]
• 2004 — Stein et al. published the 209-patient orthotopic T Pouch series (median f/u 33 mo) — antireflux T-limb provided unobstructed flow in 95% and reflux prevention in 90%; T-limb stenosis in only 4 patients (3 with adjuvant pelvic radiation).^[8]
• 2012 — Agarwal et al. (PGIMER, Chandigarh) published a modified Double T Pouch using Yang-Monti tubes — the "PGIMER Pouch" — in 8 patients.^[9]
• 2015 — The landmark USC-STAR randomized trial (Skinner EC et al., n = 484) compared the orthotopic T Pouch vs Studer Pouch — the only RCT comparing an antireflux to a non-antireflux neobladder. The T Pouch did not prevent renal function decline at 3 years and was associated with more secondary diversion-related surgeries.^[10]

The T-Mechanism — Design Principle

The T-mechanism (serosal-lined extramural ileal flap valve) is the fundamental innovation underlying both the T Pouch and the Double T Pouch.^[1][2][4][5]

1. A short segment of intact (non-detubularized) ileum is preserved on its vascular pedicle.
2. The ileal tube is laid into a trough between two adjacent limbs of the detubularized reservoir.
3. The serosal surfaces of adjacent limbs are sutured over the tube, creating a serosal-lined extramural tunnel.
4. As the reservoir fills, intraluminal pressure compresses the tube within the tunnel, preventing retrograde flow.
5. The tube can be easily catheterized because the tunnel opens with external (catheter-passing) pressure.

Critical design parameter — tunnel length-to-luminal-diameter ratio must be ≥ 2:1 for reliable valve function (Bochner pig model: a 30 Fr tube in a 1 cm tunnel leaked at 19 cm H₂O; the same tube in a 2 cm tunnel held to 100 cm H₂O).^[5]

Advantages over intussusception:^[1][2][4]

• No intussusception → no extussusception (nipple slippage)
• No staples → no stone formation on exposed staples
• Complete preservation of blood supply to the limb
• Technically simpler than creating and stabilizing an intussuscepted nipple
• No foreign material (no Marlex collar, no mesh)

Surgical Technique

The Double T Pouch applies the T-mechanism twice — once at each end of the reservoir.^[1][2]

Ileal Harvest

1. Approximately 60–70 cm of ileum is isolated; the distal 25 cm of terminal ileum is spared to preserve B12 and bile-salt absorption.
2. The segment is divided into three functional components:
   • Proximal T-limb (afferent, ~ 6–8 cm intact ileum) — antireflux mechanism for ureteral anastomosis.
   • Middle reservoir segment (~ 40–44 cm) — detubularized along the antimesenteric border, reconfigured into a W-shaped or spheroidal low-pressure reservoir.
   • Distal T-limb (efferent, ~ 6–8 cm intact ileum) — continence mechanism for the catheterizable stoma.

Reservoir Construction

3. The detubularized middle segment is folded into a W; serosal surfaces of adjacent limbs are sutured close to the mesentery.
4. The posterior wall is closed with running absorbable sutures.

Afferent T-Mechanism (Antireflux)

5. The proximal intact ileal tube is laid into the serosal-lined trough between two adjacent limbs at the proximal end.
6. The serosal surfaces are sutured over the tube, creating the extramural serosal-lined tunnel.
7. The ureters are anastomosed to the proximal end (end-to-side or Wallace).
8. As the reservoir fills, the afferent tube is compressed within the tunnel, preventing reflux.

Efferent T-Mechanism (Continence)

9. The distal intact ileal tube is laid into the serosal-lined trough at the distal end of the reservoir.
10. The serosal surfaces are sutured over the tube, creating the extramural serosal-lined tunnel.
11. The distal end is brought through the abdominal wall as a flush catheterizable stoma (RLQ or umbilicus).
12. As the reservoir fills, the efferent tube is compressed within the tunnel, preventing leakage.
13. The patient empties via 14–16 Fr catheter every 4–6 hours.

Closure

14. Anterior wall closed; ureteral stents and a Malecot / suprapubic drainage catheter placed.
15. Reservoir drained ~ 3–4 weeks before initiating CIC.

Hemi-T Pouch — Pediatric Modification

Kurzrock, Skinner, and Stein adapted the Double T Pouch concept for pediatric patients requiring bladder augmentation and continent diversion when the appendix was unavailable.^[7]

• A 10-year-old boy underwent bladder augmentation with a hemi-T augment.
• The detubularized portion augmented the native bladder; a preserved intact ileal tube was embedded in a serosal-lined tunnel as the continent catheterizable channel.
• At 1 year — continent, infection-free, bilateral hydronephrosis resolved, urodynamics showed a 350 mL reservoir without reflux.

The authors concluded that the hemi-T augment is a suitable option when the appendix is unavailable and there is minimal bladder available for implantation of a Yang-Monti conduit.

PGIMER Pouch — Modified Double T with Yang-Monti Tubes

Agarwal et al. (2012) at PGIMER, Chandigarh, simplified the construction by using Yang-Monti tubes instead of native ileal segments for the T-mechanisms.^[9]

Technique:

• ~ 45–50 cm of terminal ileum harvested (sparing 25 cm of terminal ileum).
• Proximal 3 cm and distal 3–6 cm separated on their vascular pedicles and reconfigured as Yang-Monti tubes (one proximal afferent; one or two distal efferent).
• Middle 40–45 cm detubularized as a W-shaped reservoir.
• Yang-Monti tubes implanted into the W pouch via extramural serosal-lined tunnels.
• Ureters implanted into the proximal tube using the Wallace principle.

Results (n = 8, follow-up 2 mo to 3 yr):

Parameter	Result
Patients	8 (4 exstrophy, 2 bladder cancer, 1 vaginal cancer, 1 prostate cancer)
Ureteroileal anastomotic obstruction	0/15 anastomoses
Catheterization difficulty	None
Antireflux success	14/15 anastomoses (93.3%) nonrefluxing
Early complications	Intestinal obstruction (2), ureteroileal leak (3), vesico-ileocutaneous fistula (1)

The authors concluded the technique was technically feasible and relatively simple in nonirradiated ileum, but early complications indicated a learning curve and called for longer follow-up.^[9]

Functional Outcomes — Cutaneous T Pouch (Marino & Laudi 2002)

The first independent clinical series of the cutaneous T Pouch.^[6]

Parameter	Result
Patients	18 (mean age 68 yr)
Indication	Radical cystectomy for invasive bladder cancer involving bladder neck / urethra / prostate
Follow-up	Mean 12 mo (range 4–20)
Continence	100% day and night
Late complications	None
Capacity	Good
Pressure	Low
Reflux	None
Catheterization difficulty	None — evacuation intervals ~ 4 hours

The first 5 patients were reconstructed using the original orthotopic T-pouch configuration; subsequent patients had a simplified technique reducing required ileal segments. The ureteric-intestinal anastomosis used a split-cuff nipple technique.

Orthotopic T Pouch Outcomes for Reference (Stein 2004, n = 209)

While this series evaluated the orthotopic (not cutaneous) T Pouch, it provides the largest dataset on T-mechanism performance.^[8]

Parameter	Result
Patients	209 (169 men, 40 women; mean age 69)
Median follow-up	33 mo
Perioperative mortality	1.4%
Early complications	30% total (5% diversion-related)
Late complications	32% total (18% diversion-related)
T-limb stenosis	4 patients (3 had adjuvant pelvic radiation)
Reflux	10% (15/158 evaluable)
Ureteroileal obstruction	9 patients
Pouch calculi	17 patients (most common late diversion-related complication)
Normal upper tracts	90% (162/181)
Renal function stable / improved	96%
Daytime continence	87%
Nighttime continence	72%
CIC required	25% overall (20% men, 43% women)

USC-STAR Trial — T Pouch vs Studer Pouch (RCT)

The only RCT comparing an antireflux neobladder (T Pouch) to a non-antireflux neobladder (Studer); 484 patients.^[10]

Parameter	T Pouch (n = 237)	Studer Pouch (n = 247)	p
eGFR decline at 3 yr	6.6 mL/min/1.73 m²	6.4 mL/min/1.73 m²	0.35 (NS)
Type of neobladder independently associated with renal-function decline	No (p = 0.63 on MVA)	—	—
Cumulative UTI risk	No difference	No difference	NS
Overall late complications	No difference	No difference	NS
Secondary diversion-related surgeries	Increased	—	Significant

Key conclusions. The T Pouch antireflux mechanism did not prevent the moderate renal-function decline observed at 3 years compared to Studer, and was associated with more secondary surgeries. Independent predictors of renal-function decline were baseline eGFR, age, and urinary-tract obstruction — not the type of neobladder. This trial fundamentally challenged the premise that antireflux mechanisms are necessary in low-pressure ileal reservoirs — and by extension, the rationale for the antireflux limb of the Double T Pouch.^[10]

Comparison with Other Continent Cutaneous Diversions

Feature	Double T Pouch	Kock Pouch	Indiana Pouch	Mainz Pouch I
Bowel segment	Ileum only	Ileum only	Right colon + terminal ileum	Cecum + 2 ileal loops
Antireflux mechanism	Serosal-lined T-mechanism (afferent)	Intussuscepted afferent nipple	Ileocecal valve ± tunneled	Submucosal tunnel or SLET
Continence mechanism	Serosal-lined T-mechanism (efferent)	Intussuscepted efferent nipple	Plicated/tapered terminal ileum	Appendix or intussuscepted nipple
Intussusception required	No	Yes (both limbs)	No	Optional
Staples / foreign material	None	Staples ± Marlex	None / minimal	Staples (nipple variant)
Blood-supply preservation	Complete	Compromised by intussusception	Preserved	Preserved (appendix)
Stone formation risk	Low (no exposed staples)	High (16.7–44%)	Moderate (5.4–19%)	Moderate (5.6–10.8%)
Continence rate	100% (small series)	84–95%	89–100%	82–92.8%
Reoperation rate	Not well established	22–53%	10.8–22%	11–36%
Series size	Small (8–18 patients)	Hundreds	Hundreds	> 800

Strengths and Limitations

Strengths

• Eliminates intussusception entirely — removing the primary source of Kock pouch complications.^[1][2][4]
• No foreign material — no staples, no Marlex collar — reducing stone formation and erosion risk.^[1][2]
• Complete blood-supply preservation to both afferent and efferent limbs.^[1][4]
• Uses ileum only — preserves the ileocecal segment for GI function.^[2][6]
• Versatile T-mechanism principle — applicable as antireflux, continence, or both, and adaptable to bladder augmentation (Hemi-T).^[1][2][7]
• Excellent early continence — 100% in the Marino series.^[6]
• Validated in animal model — fluorourodynamic studies confirmed reliable valve function at tunnel-to-diameter ratio ≥ 2:1.^[5]

Limitations

• Limited clinical data — small series (8–18 patients), short follow-up (up to 3 yr); long-term durability of the serosal-lined tunnel as a continence mechanism remains unproven.^[2][6][9]
• USC-STAR trial implications — the T-mechanism's antireflux function did not translate into superior renal-function preservation compared to the non-antireflux Studer Pouch, and was associated with more secondary surgeries. This fundamentally challenges the rationale for adding the antireflux T-mechanism.^[10]
• T-limb stenosis — 2% in the orthotopic series, with disproportionate risk in irradiated patients.^[8]
• Pouch calculi — remained the most common late diversion-related complication (8.1%) even without exposed staples — stone formation in ileal reservoirs is multifactorial.^[8]
• Learning curve — the PGIMER series reported significant early complications attributed to the learning curve.^[9]
• Technical complexity — two serosal-lined tunnels add operative time vs simpler appendix or plicated-ileum alternatives.^[2]

Current Status and Legacy

1. The Double T Pouch demonstrated that the serosal-lined extramural tunnel could serve as both antireflux and continence mechanism — a single biophysical principle solving both fundamental challenges of continent diversion.^[1][2]
2. Provided a purely ileal continent cutaneous diversion that avoided intussusception, staples, and foreign materials.^[2][4]
3. The USC-STAR trial ultimately undermined the clinical rationale for the antireflux T-mechanism by showing no renal-function benefit over the simpler Studer Pouch with more secondary surgeries.^[10]
4. The PGIMER modification with Yang-Monti tubes demonstrated that the Double T concept could be simplified, though long-term data remain lacking.^[9]

In current practice, the Double T Pouch is rarely performed as a standalone technique. Continent cutaneous diversion has moved toward simpler, well-validated approaches — particularly the Indiana Pouch and appendicovesicostomy — which have larger evidence bases and lower technical complexity.^[11][12] The serosal-lined extramural tunnel principle remains an important tool, particularly when the appendix is unavailable and a purely ileal construction is desired.^[2][13]

Key Takeaways

1. The Double T Pouch is a USC ileal continent cutaneous reservoir applying the serosal-lined extramural T-mechanism at both ends — antireflux (afferent) + continence (efferent).^[1][2]
2. The T-mechanism eliminates intussusception, staples, and foreign material — removing the principal Kock pouch failure modes — and is validated in animal models with a required tunnel length-to-diameter ratio ≥ 2:1.^[4][5]
3. Limited clinical data (n ≈ 8–18 across cohorts) show 100% early continence in the Marino series; no late complications at short follow-up.^[6]
4. The USC-STAR RCT fundamentally challenges the antireflux rationale — the T-mechanism did not prevent renal-function decline at 3 yr and was associated with more secondary surgeries.^[10]
5. Hemi-T (Kurzrock 2003) and PGIMER Yang-Monti (Agarwal 2012) modifications demonstrate the T-mechanism's adaptability when the appendix is unavailable.^[7][9]
6. Currently rarely performed as a standalone technique; the underlying serosal-lined extramural tunnel principle remains valuable in the broader reconstructive armamentarium.^[2][13]

See Also

• Urinary Diversion Principles
• T-Pouch Modification
• Indiana Pouch
• Kock Pouch
• Mansoura Neobladder
• Mainz Pouch I
• Modified Studer Pouch

References

1. Stein JP, Skinner DG. "T-Mechanism Applied to Urinary Diversion: The Orthotopic T-Pouch Ileal Neobladder and Cutaneous Double-T-Pouch Ileal Reservoir." Tech Urol. 2001;7(3):209–22. PMID: 11704859

2. Stein JP, Skinner DG. "The Craft of Urologic Surgery: The T Pouch." Urol Clin North Am. 2003;30(3):647–61. doi:10.1016/s0094-0143(03)00033-8

3. Skinner DG, Lieskovsky G, Boyd SD. "Continent Urinary Diversion. A 5 1/2 Year Experience." Ann Surg. 1988;208(3):337–44. doi:10.1097/00000658-198809000-00011

4. Stein JP, Lieskovsky G, Ginsberg DA, Bochner BH, Skinner DG. "The T Pouch: An Orthotopic Ileal Neobladder Incorporating a Serosal Lined Ileal Antireflux Technique." J Urol. 1998;159(6):1836–42. doi:10.1016/S0022-5347(01)63170-7

5. Bochner BH, Stein JP, Ginsberg DA, et al. "A Serous Lined Antireflux Valve: In Vivo Fluorourodynamic Evaluation of Antireflux Continence Mechanism." J Urol. 1998;160(1):112–5. doi:10.1016/s0022-5347(01)63049-0

6. Marino G, Laudi M. "Ileal T-Pouch as a Urinary Continent Cutaneous Diversion: Clinical and Urodynamic Evaluation." BJU Int. 2002;90(1):47–50. doi:10.1046/j.1464-410x.2002.02784.x

7. Kurzrock E, Skinner DG, Stein JP. "Hemi-T Pouch Modification for Pediatric Urinary Diversion." J Urol. 2003;170(3):949–51. doi:10.1097/01.ju.0000080329.28607.bc

8. Stein JP, Dunn MD, Quek ML, Miranda G, Skinner DG. "The Orthotopic T Pouch Ileal Neobladder: Experience With 209 Patients." J Urol. 2004;172(2):584–7. doi:10.1097/01.ju.0000131651.77048.73

9. Agarwal MM, Mavuduru R, Singh SK, Mandal AK. "Preliminary Short-Term Outcomes of a Modified Double-T Ileal Continent Cutaneous Urinary Diversion Using Yang-Monti Tube Implantation Through Serosa-Lined Extramural Tunnel: The PGIMER Pouch." Urology. 2012;79(4):943–9. doi:10.1016/j.urology.2011.12.026

10. Skinner EC, Fairey AS, Groshen S, et al. "Randomized Trial of Studer Pouch Versus T-Pouch Orthotopic Ileal Neobladder in Patients With Bladder Cancer." J Urol. 2015;194(2):433–9. doi:10.1016/j.juro.2015.03.101

11. Fisch M, Thüroff JW. "Continent Cutaneous Diversion." BJU Int. 2008;102(9 Pt B):1314–9. doi:10.1111/j.1464-410X.2008.07976.x

12. Pearce SM, Daneshmand S. "Continent Cutaneous Diversion." Urol Clin North Am. 2018;45(1):55–65. doi:10.1016/j.ucl.2017.09.004

13. Abdelhalim A, Soltan MA, Helmy TE, Dawaba ME, Hafez AT. "Ileal Neobladder With a Continent Cutaneous Catheterizable Channel Using the Extramural Serous Lined (Mansoura) Technique in a Bladder Exstrophy Patient." Urology. 2020;146:302. doi:10.1016/j.urology.2020.09.021